Comments
Commented by Lars Winter on June 25th, 2026 | 07:20 CEST
Lahontan Gold: This Stock Is Poised for a Breakout
Lahontan Gold is one of the most exciting stocks in the gold mining sector. The Canadian small-cap stock has more than tripled in value over the past year and could be poised for its next big move, as the North American company's business model still holds significant growth potential. This is likely to be confirmed by a new PEA set to be released in the coming months. Lahontan has also recently made several advances in its drilling activities, which could now give this hot stock new momentum.
Read
Commented by Fabian Lorenz on June 25th, 2026 | 07:15 CEST
Shockwaves in the German defence sector! TKMS Surges! Will drone specialist Volatus Aerospace and Heidelberger Druckmaschinen be next?
The German government has sent shockwaves through the German defence sector. While Rheinmetall's stock briefly plummeted by more than 16% on Wednesday, TKMS's stock rose by over 10%. The trigger was a "Spiegel" report confirmed by the Ministry of Defence. According to the report, the German government is ending the severely delayed and significantly more expensive F126 frigate program. This puts Rheinmetall's medium-term plans at risk. At the same time, TKMS could benefit. Volatus Aerospace is capitalizing on the drone boom. With a new location, the company aims to grow in the civilian and military drone market. If it succeeds in monetizing its 500 million dollar pipeline more effectively, the stock should take off again. Heidelberger Druckmaschinen is in the midst of transforming itself from a printing press manufacturer into an industrial and technology company. In the future, it also plans to get involved in drone defence. While there is still a rocky road ahead, analysts recommend buying the stock.
Read
Commented by Matthias Schomber on June 25th, 2026 | 07:10 CEST
Stock Market Thriller 2026: Novo Nordisk Under Pressure, Deutsche Telekom at EUR 26, and Antimony Resources on the Attack!
Created and published on behalf of Antimony Resources Corp.
The stock market is currently a world of extremes. While former high-flyer Novo Nordisk, once Europe's most valuable company, is grappling with sharp corrections and mounting competitive pressure, the established telecommunications giant Deutsche Telekom is quietly building the digital future of Germany and Europe. However, the stock is currently fighting what is likely the most important battle of the year against a critical chart level that will determine its future price trajectory. Yet the most exciting stories are often not written by mega-cap companies, but by smaller companies with significant growth potential. In this report, we take a closer look at three stocks. We begin with pharmaceutical heavyweight Novo Nordisk, then examine Deutsche Telekom's AI ambitions and the importance of its key technical price level. Finally, we turn our attention to an intriguing Canadian resource explorer that may be on the verge of a major breakout. The focus is on antimony, and the company is Antimony Resources. Sit back and discover hidden opportunities in today's market with us.
Read
Commented by Armin Schulz on June 25th, 2026 | 07:05 CEST
Tungsten as a Bottleneck: A Good Entry Point for Almonty Industries? Alarm Bells Ringing at Rheinmetall! Intel on the Rise!
Tungsten prices have skyrocketed in recent months. Inventories are dwindling, and China is curbing exports. Demand from the defense, semiconductor, and medical technology sectors is outpacing supply. Analysts are warning of structural shortages. The price per metric ton unit (MTU)—equivalent to 10 kg—has been above the USD 3,000 mark for some time now. The metal is becoming a critical bottleneck for armour, processors, and high-tech applications. To avoid this dependency, there are only a few Western producers. Almonty Industries, which holds one of the largest tungsten deposits outside of China, is increasingly moving into focus. Alongside this, we take a closer look at the current situation at the defense company Rheinmetall and the semiconductor manufacturer Intel.
Read
Commented by Tarik Dede on June 25th, 2026 | 07:00 CEST
Uranium, Lithium, Oil: A Stock Analysis of PLS Group, American Atomics, and TotalEnergies
Energy, energy, energy! This is a critical issue—and not just at a time when Europe desperately needs more air conditioning. The AI revolution is driving demand for solutions at an unprecedented rate. The US is particularly affected, as the expansion of data centers there is proceeding at a rapid pace. Analysts estimate that the so-called AI hyperscalers will invest more than USD 700 billion in expansion this year. The US power grid is not equipped to handle this, so utilities, solar and wind farm developers, as well as natural gas companies, are currently benefiting the most. But in addition to AI, the growth of the electric vehicle fleet is also a major issue. And last but not least, parts of the European power grid also need to be expanded and modernized. Demand for lithium, uranium, and oil is therefore likely to grow steadily in the coming years and decades. That is why today we are taking a closer look at the stocks of PLS Group, American Atomics, and TotalEnergies.
Read
Commented by Fabian Lorenz on June 24th, 2026 | 08:50 CEST
A bombshell at Siemens Energy! Chevron and Microsoft are stepping on the gas amid the AI boom! Zefiro Methane Benefits Indirectly!
A bombshell at Siemens Energy. "Manager Magazin" reports that the DAX-listed company plans to spin off a division. Analysts would welcome such a move, as it would allow the company to focus more strongly on its gas turbine business, among other areas. These turbines are in high demand amid the AI boom in the US. This is also reflected in the recent deal between Chevron and Microsoft, in which the energy company is set to build a gas-fired power plant in Texas, right next to a new AI data center. This illustrates how oil and gas development continues in the US. However, there are already significant challenges associated with legacy infrastructure. Of the estimated 2.2 million abandoned wells, many pose serious environmental and safety risks. Monitoring and plugging these wells is a niche market worth billions. Zefiro Methane operates in this segment and aims to expand significantly in the coming years. The stock appears far from expensive.
Read
Commented by André Will-Laudien on June 24th, 2026 | 08:45 CEST
AI and Chip Sell-Off! Watch Out for SMCI, AMD, and Infineon; First Hydrogen in the Innovation Race
The stock market is currently showing no mercy. After months of gains in AI, high-tech, and chip stocks, the market has now shifted into profit-taking mode—and, at times, even sell-off mode. What analysts have been predicting for quite some time is increasingly coming to pass. The global stock market rally, driven by the NASDAQ, is taking its toll. While the long-term earnings outlook may be solid, short-term price surges of up to 2,000% in just 12 months no longer indicate a healthy market trend. So, while it comes as no surprise, it may be unwelcome for many market participants: a sharper downward move—one that, however, also brings new opportunities in its wake. We examine the fundamental framework of the key players and highlight alternatives for getting off to an innovative start today. The stock market keeps turning—just a little slower at times!
Read
Commented by Fabian Lorenz on June 24th, 2026 | 08:40 CEST
Alarm at BMW! Sell-off at BioNTech! Desert Gold Undervalued!
Alarm at BMW. First, the company shocked shareholders with a profit warning. Now, business in China has collapsed. Analysts are finally reacting by slashing their estimates and price targets. Is it time to buy now? From the perspective of GBC Research, Desert Gold is the stock to buy right now. The company is set to transition from an explorer to a gold producer this summer. Analysts see its intrinsic value well above current price levels. And what about BioNTech? The share has been trading sideways for months. The announcement of location closures has drawn heavy criticism. Shareholders are equally disillusioned. Could rival Moderna, of all companies, now bring hope to the workforce?
Read
Commented by Matthias Schomber on June 24th, 2026 | 08:35 CEST
Allianz Breaks the Record, Siemens Energy Is on a Roll, and Is HPQ Silicon on the Verge of a Breakthrough?
The stock market is currently producing stories as different as one could possibly imagine. On one hand, we are witnessing impressive rallies—especially in the AI sector and among AI-related stocks—as well as historic milestones at established German blue-chip companies such as Allianz. Record profits and full order books are pushing share prices to levels unimaginable just a few years ago. On the other hand, smaller technology companies are stepping into the spotlight, aiming to revolutionize entire industries with fresh ideas and smart partnerships. Today, we take a detailed look at this fascinating mix. We examine the rapid resurgence of a true energy heavyweight from Germany: Siemens Energy. We analyze the historic breakout of a Munich-based insurance giant: Allianz. And we highlight a Canadian materials specialist whose stock is approaching a decisive technical level and comes with highly intriguing news flow: HPQ Silicon. Take a moment to explore three completely different investment ideas, each carrying its own potential for excitement—and possibly gains—in your portfolio.
Read
Commented by Armin Schulz on June 24th, 2026 | 08:30 CEST
Cancer remains the hottest bet in the pharmaceutical market: Bayer, Vidac Pharma, and Pfizer are competing for the next generation of therapies
The oncology market is the most dynamic segment of the pharmaceutical industry. While global heavyweights are positioning their multibillion-dollar pipelines, a small biotech company is banking on a scientific approach that directly targets the metabolism of tumour cells. For investors, the key question is whether the future of cancer treatment will be defined by broad-based therapies, targeted antibody-drug conjugates, or precise interventions at the cellular metabolic level. The differing approaches taken by Bayer, Vidac Pharma, and Pfizer promise to set the course not only medically but also financially for the coming decade.
Read